Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
I Puls, J Mohr, J Wrase, J Priller, J Behr, W Kitzrow, N Makris, H C Breiter, K Obermayer, A Hein. Synergistic effects of the dopaminergic and glutamatergic system on hippocampal volume in alcohol-dependent patients. Biological psychology. vol 79. issue 1. 2008-10-23. PMID:18423838. |
several genes of the dopaminergic and glutamatergic neurotransmitter systems have been found to be associated with alcohol disease and related intermediate phenotypes. |
2008-10-23 |
2023-08-12 |
Not clear |
Bernard Le Foll, Zuzana Justinova, Gianlugi Tanda, Steven R Goldber. [Future medications for tobacco and cannabis dependence]. Bulletin de l'Academie nationale de medecine. vol 192. issue 1. 2008-10-16. PMID:18663981. |
although the dopaminergic system plays a critical role in reinforcing the effects of drugs of abuse, other neurotransmitter systems are also involved. |
2008-10-16 |
2023-08-12 |
Not clear |
Boris B Quednow, Philipp A Csomor, Joelle Chmiel, Thilo Beck, Franz X Vollenweide. Sensorimotor gating and attentional set-shifting are improved by the mu-opioid receptor agonist morphine in healthy human volunteers. The international journal of neuropsychopharmacology. vol 11. issue 5. 2008-09-24. PMID:18272020. |
animal and human studies have shown that ppi can be modulated by dopaminergic, serotonergic, and glutamatergic drugs and consequently it was proposed that impaired sensorimotor gating in schizophrenia parallels a central abnormality within the corresponding neurotransmitter systems. |
2008-09-24 |
2023-08-12 |
human |
Teresa Cunha-Oliveira, Ana Cristina Rego, Catarina R Oliveir. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain research reviews. vol 58. issue 1. 2008-09-11. PMID:18440072. |
the drugs of abuse directly or indirectly affect neurotransmitter systems, particularly dopaminergic and glutamatergic neurons. |
2008-09-11 |
2023-08-12 |
Not clear |
Simon F Crowe, Joanne M Sherry, Matthew W Hal. Remembering that things have changed: a review of the cellular mechanisms of memory re-consolidation in the day-old chick. Brain research bulletin. vol 76. issue 3. 2008-09-04. PMID:18498931. |
the re-processing of the memory following a re-consolidation involves each of the glutamatergic, adrenergic and dopaminergic neurotransmitter systems as well as re-activation of protein synthesis associated with the respective traces. |
2008-09-04 |
2023-08-12 |
human |
U Meyer, A Engler, L Weber, M Schedlowski, J Feldo. Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience. vol 154. issue 2. 2008-08-29. PMID:18495356. |
using a mouse model of prenatal immune challenge by the viral mimic polyriboinosinic-polyribocytidilic acid (polyi:c), we explored the acute effects of maternal immune activation during pregnancy on the development of the fetal dopaminergic system, a neurotransmitter system known to be affected in schizophrenia and related disorders. |
2008-08-29 |
2023-08-12 |
mouse |
Nancy Laurin, Abel Ickowicz, Tejaswee Pathare, Molly Malone, Rosemary Tannock, Russell Schachar, James L Kennedy, Cathy L Bar. No evidence for genetic association between DARPP-32 (PP1R1B) polymorphisms and attention deficit hyperactivity disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 147. issue 3. 2008-08-08. PMID:17948899. |
the dopamine- and camp-regulated phosphoprotein of relative molecular mass of 32 kda (darpp-32) is a key component of dopamine signaling, acting as a converging point for several neurotransmitter systems influencing dopaminergic neurons and regulating a wide variety of downstream effectors. |
2008-08-08 |
2023-08-12 |
human |
Susanne Brummelte, Thorsten Grund, Gunther H Moll, Gertraud Teuchert-Noodt, Ralph R Dawir. Environmental enrichment has no effect on the development of dopaminergic and GABAergic fibers during methylphenidate treatment of early traumatized gerbils. Journal of negative results in biomedicine. vol 7. 2008-07-30. PMID:18485211. |
on postnatal day (pd) 14, which is known to cause multiple changes in the subsequent development of several neurotransmitter systems including the dopaminergic systems, and were then treated with oral daily applications of mp (5 mg/kg) from pd30-60. |
2008-07-30 |
2023-08-12 |
Not clear |
Sebastiaan Engelborghs, Ellen Vloeberghs, Nathalie Le Bastard, Michael Van Buggenhout, Peter Mariën, Nore Somers, Guy Nagels, Barbara A Pickut, Peter P De Dey. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochemistry international. vol 52. issue 6. 2008-07-28. PMID:18093695. |
the dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. |
2008-07-28 |
2023-08-12 |
Not clear |
Dianne Currier, J John Man. Stress, genes and the biology of suicidal behavior. The Psychiatric clinics of North America. vol 31. issue 2. 2008-07-24. PMID:18439448. |
these neurotransmitter systems include the serotonergic, noradrenergic, and dopaminergic systems and the hypothalamic-pituitary-adrenal axis. |
2008-07-24 |
2023-08-12 |
Not clear |
Philip A Robinso. Protein stability and aggregation in Parkinson's disease. The Biochemical journal. vol 413. issue 1. 2008-07-03. PMID:18537793. |
the reason that dopaminergic neurons are particularly sensitive may be due to the additional cellular stress caused by the breakdown of the inherently chemically unstable neurotransmitter, dopamine. |
2008-07-03 |
2023-08-12 |
Not clear |
Nicola Palomero-Gallagher, Axel Schleicher, Sven Lindemann, Alina Lessenich, Karl Zilles, Wolfgang Lösche. Receptor fingerprinting the circling ci2 rat mutant: insights into brain asymmetry and motor control. Experimental neurology. vol 210. issue 2. 2008-06-20. PMID:18255063. |
our data add to the hypothesis that motor disorders such as hyperkinesias cannot be explained solely by absolute functional increases or decreases in the dopaminergic system, but are due to imbalances in several neurotransmitter systems. |
2008-06-20 |
2023-08-12 |
rat |
G Z Ziiazetdinova, A Ia Sapronova, V Ia Kiiasova, A K Nanaev, V S Kudrin, N Martina, I Tyllet, M V Ugriumo. [Compensatory reaction during degeneration of arcuate nucleus dopaminergic neurons in rats]. Zhurnal evoliutsionnoi biokhimii i fiziologii. vol 44. issue 1. 2008-06-03. PMID:18411516. |
the study has been carried out to verify the authors' hypothesis that degeneration of dopaminergic (da-ergic) neurons of the hypothalamic tuberoinfundibular system and concomitant development of hyperprolactinemia are accompanied by involvement of compensatory synthesis of dopamine (da) by non-dopaminergic neurons expressing single complementary enzymes of synthesis of this neurotransmitter. |
2008-06-03 |
2023-08-12 |
rat |
Lars Nyb. Hyperthermia and fatigue. Journal of applied physiology (Bethesda, Md. : 1985). vol 104. issue 3. 2008-05-23. PMID:17962572. |
the cns fatigue appears to be influenced by neurotransmitter activity of the dopaminergic system, but may primarily relate to inhibitory signals from the hypothalamus arising secondary to an increase in brain temperature. |
2008-05-23 |
2023-08-12 |
Not clear |
K Herholz, S F Carter, M Jone. Positron emission tomography imaging in dementia. The British journal of radiology. vol 80 Spec No 2. 2008-05-15. PMID:18445746. |
it is also possible to investigate neurotransmitter systems in dementia; targets have included the cholinergic, dopaminergic and serotonergic systems. |
2008-05-15 |
2023-08-12 |
Not clear |
Kevin B Freeman, Andrey Verendeev, Anthony L Rile. Noradrenergic antagonism enhances the conditioned aversive effects of cocaine. Pharmacology, biochemistry, and behavior. vol 88. issue 4. 2008-05-08. PMID:18045672. |
there is some evidence that cocaine's aversive effects, as indexed in the conditioned taste aversion (cta) preparation, are catecholaminergically mediated, i.e., through cocaine's actions on the dopaminergic and noradrenergic neurotransmitter systems. |
2008-05-08 |
2023-08-12 |
Not clear |
Anupom Borah, Kochupurackal P Mohanakuma. Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats. Cellular and molecular neurobiology. vol 27. issue 8. 2008-05-01. PMID:17934805. |
in the present study we investigated 5-hydroxytryptamine (5-ht) and dopamine concentrations in serotonergic and dopaminergic nuclei following chronic administration of l-dopa to find whether the neurotransmitter synthesis in these brain areas are compensated. |
2008-05-01 |
2023-08-12 |
rat |
Alida Filippi, Katrin Dürr, Soojin Ryu, Marc Willaredt, Jochen Holzschuh, Wolfgang Drieve. Expression and function of nr4a2, lmx1b, and pitx3 in zebrafish dopaminergic and noradrenergic neuronal development. BMC developmental biology. vol 7. 2008-04-25. PMID:18053265. |
the transcription factors pitx3 and lmx1b play an important role in mammalian mesencephalic dopaminergic specification, and nurr1/nr4a2 has been shown to contribute to specification of the dopaminergic neurotransmitter phenotype. |
2008-04-25 |
2023-08-12 |
zebrafish |
A Carmona, G Devès, R Orteg. Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques. Analytical and bioanalytical chemistry. vol 390. issue 6. 2008-04-18. PMID:18246461. |
we found that the iron content increases in dopaminergic cells exposed to an excess iron, with marked accumulation within distal ends, suggesting interaction between iron and dopamine within neurotransmitter vesicles. |
2008-04-18 |
2023-08-12 |
Not clear |
Daniel J Guillaume, Su-Chun Zhan. Human embryonic stem cells: a potential source of transplantable neural progenitor cells. Neurosurgical focus. vol 24. issue 3-4. 2008-04-17. PMID:18341406. |
more recent progress has been made in further directing them into becoming cells with specialized regional and neurotransmitter identities, such as midbrain dopaminergic and spinal motor neurons. |
2008-04-17 |
2023-08-12 |
human |